Femasys Inc. (FEMY)
NASDAQ: FEMY · Real-Time Price · USD
1.180
-0.010 (-0.84%)
At close: Jan 31, 2025, 4:00 PM
1.150
-0.030 (-2.54%)
After-hours: Jan 31, 2025, 6:11 PM EST

Femasys Revenue

Femasys had revenue of $554.91K in the quarter ending September 30, 2024, with 127.09% growth. This brings the company's revenue in the last twelve months to $1.26M, up 15.33% year-over-year. In the year 2023, Femasys had annual revenue of $1.07M, down -11.13%.

Revenue (ttm)
$1.26M
Revenue Growth
+15.33%
P/S Ratio
20.51
Revenue / Employee
$37,078
Employees
34
Market Cap
27.02M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 20231.07M-134.25K-11.13%
Dec 31, 20221.21M26.53K2.25%
Dec 31, 20211.18M141.77K13.66%
Dec 31, 20201.04M108.85K11.72%
Dec 31, 2019929.06K--
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
UnitedHealth Group 400.28B
Johnson & Johnson 88.82B
Merck & Co. 63.17B
AbbVie 55.53B
AstraZeneca 51.21B
Novartis AG 49.94B
Thermo Fisher Scientific 42.88B
Abbott Laboratories 41.95B
Revenue Rankings